Owlet

OWLT

----

Current ValuationThe current P/E ratio is -11.37, below the reasonable range, cheaper than 96.32% of the time in the past 5 years, and the industry ranks 132/174, the industry Median -0.98.

-11.37xP/E

Stock price$5.06Earnings per share$-0.44

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
BAXUSBaxter	-11.78x	141.71%	$12.52B
GKOSUSGlaukos	-51.44x	75.37%	$9.67B
TFXUSTeleflex	-5.14x	118.39%	$5.31B
PLSEUSPulse Biosciences	-44.99x	27.55%	$3.60B
IRTCUSIRhythm	-257.83x	73.29%	$3.60B
BFLYUSButterfly Network	-33.37x	34.41%	$2.50B
AXGNUSAxogen	-65.09x	18.38%	$2.18B
ASSTUSStrive	-2.15x	63.23%	$2.09B
NVCRUSNovocure	-11.91x	1.23%	$1.77B
KMTSUSKestra Medical Tech	-11.08x	0.94%	$1.66B
ATECUSAlphatec	-15.05x	41.67%	$1.66B
DRTSUSAlpha Tau Medical	-14.85x	--	$1.37B
TNDMUSTandem Diabetes	-18.15x	77.60%	$1.15B
AORTUSArtivion	-345.46x	266.67%	$1.10B
ENOVUSEnovis	-0.98x	100.97%	$1.08B
IARTUSIntegra LifeSciences	-142.82x	109.42%	$1.03B
PRCTUSPROCEPT BioRobotics	-9.30x	3.47%	$1.02B
BBNXUSBeta Bionics	-13.67x	13.22%	$997.56M
CBLLUSCeribell	-14.46x	35.15%	$954.08M
SIBNUSSI-BONE	-60.68x	8.85%	$887.86M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.